Bgm Group Ltd's ability to collect accounts receivable sequentially worsen to 4.12, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Bgm Group Ltd's Accounts Receivable average collection period in the Sep 30 2024 quarter, has increased to 89 days, from 23 days, in the 0 quarter.

If we take a look into Healthcare sector 73 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2024 from 718 to 748.

What is Receivable Turnover Ratio?
What is Bgm Group Ltd Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BGM Receivables Turnover Ratio	(Sep 30 2024) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Sep 30 2023) IV. Quarter
Y / Y Receivable Change	770.25 %	2484.87 %	-21.89 %	638.7 %	-21.89 %
Y / Y Revenue Change	-47.29 %	-	-	-	-29.46 %
Receivable Turnover Ratio (TTM)	4.12	15.91	35.12	32.43	45.46
BGM's Total Ranking	# 748	# 718	# 0	# 0	# 0
Accounts Receivable average collection period days	89	23	10	11	8
Seq. Receivable Change	105.1 %	324.31 %	-17.53 %	21.26 %	509.2 %
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 32
Healthcare Sector	# 74
Overall Market	# 748

Receivable Turnover Ratio Statistics
High	Average	Low
32.94	24.28	15.63
(Sep 30 2021)		(Sep 30 2024)

BGM Company Profile • Back to BGM Efficiency Comparisons • Compare BGM Receivables Turnover Ratio to its Competitors

Financial Statements
Bgm Group Ltd's Accounts Receivable	$ 13 Millions	Visit BGM's Balance sheet
Bgm Group Ltd's Sales TTM	$ 24 Millions	Visit BGM's Income Statement
Sources of BGM's Revenues		Visit BGM's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
BGM's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
BGM's Growth Rates	BGM's Roa	BGM's Inventory Turnover Ratio	BGM's Dividend Comparisons
BGM's Profitability Ratios	BGM's Roi	BGM's Asset Turnover Ratio	BGM's Dividend Growth
BGM's Valuation Ratios	BGM's Roe	BGM's Financial Strength Ratios	BGM's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2024	Receivable at quarter ending Sep 30 2024
Accelerate Diagnostics Inc	4.93	$ 11.282 Millions	$ 2.289 Millions
Yunhong Green Cti Ltd	4.93	$ 17.240 Millions	$ 3.500 Millions
Vanda Pharmaceuticals Inc	4.91	$ 190.858 Millions	$ 38.871 Millions
Avanos Medical Inc	4.91	$ 649.000 Millions	$ 132.250 Millions
Veru Inc	4.91	$ 15.814 Millions	$ 3.224 Millions
Neurocrine Biosciences Inc	4.88	$ 2,242.800 Millions	$ 459.825 Millions
Mirum Pharmaceuticals Inc	4.87	$ 307.028 Millions	$ 62.982 Millions
Privia Health Group Inc	4.85	$ 1,716.318 Millions	$ 353.968 Millions
T2 Biosystems Inc	4.85	$ 7.677 Millions	$ 1.585 Millions
Orthopediatrics Corp	4.83	$ 188.186 Millions	$ 38.937 Millions
Ptc Therapeutics inc	4.83	$ 900.664 Millions	$ 186.402 Millions
Healthlynked Corp	4.83	$ 3.321 Millions	$ 0.688 Millions
Ge Healthcare Technologies Inc	4.82	$ 16,399.000 Millions	$ 3,402.500 Millions
Abbvie Inc	4.80	$ 55,533.000 Millions	$ 11,575.000 Millions
Innoviva Inc	4.79	$ 413.572 Millions	$ 86.281 Millions
Tenon Medical Inc	4.76	$ 3.451 Millions	$ 0.725 Millions
Therapeutic Solutions International Inc	4.76	$ 0.085 Millions	$ 0.018 Millions
Scpharmaceuticals Inc	4.73	$ 30.278 Millions	$ 6.399 Millions
Organogenesis Holdings Inc	4.72	$ 455.038 Millions	$ 96.341 Millions
Cryo cell International Inc	4.72	$ 31.838 Millions	$ 6.752 Millions
Cue Biopharma Inc	4.71	$ 9.532 Millions	$ 2.024 Millions
Tarsus Pharmaceuticals Inc	4.70	$ 129.621 Millions	$ 27.555 Millions
Davita Inc	4.70	$ 12,666.614 Millions	$ 2,692.868 Millions
Biomerica Inc	4.69	$ 5.509 Millions	$ 1.174 Millions
Butterfly Network Inc	4.69	$ 75.171 Millions	$ 16.017 Millions
Regen Biopharma Inc	4.69	$ 0.237 Millions	$ 0.050 Millions
Xeris Biopharma Holdings Inc	4.68	$ 187.361 Millions	$ 40.047 Millions
Karyopharm Therapeutics Inc	4.65	$ 148.442 Millions	$ 31.954 Millions
Kewaunee Scientific Corporation	4.64	$ 199.109 Millions	$ 42.901 Millions
Amgen Inc	4.60	$ 32,534.000 Millions	$ 7,073.750 Millions

Date modified: 2026-07-23T01:54:12+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.